Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl/phenyl)-3-(4-(5-substituted-1,3,4-oxadiazol-2-yl) phenyl) quinazolin-4(3H )-ones as NMDA receptor inhibitor

Author:

Saravanan Govindaraj1,Panneerselvam Theivendren2ORCID,Kunjiappan Selvaraj3ORCID,Parasuraman Pavadai4,Alagarsamy Veerachamy1,Udayakumar Padmaja5,Soundararajan Muthukrishnan26,Joshi Shrinivas D.7,Ramalingam Suresh8,Ammunje Damodar Nayak9

Affiliation:

1. Department of Pharmaceutical Chemistry; MNR College of Pharmacy; Sangareddy Telangana India

2. Department of Pharmaceutical Chemistry; Karavali College of Pharmacy; Mangalore Karnataka India

3. International Research Center; Kalasalingam University; Krishnan Koil Tamil Nadu India

4. Department of Pharmaceutical Chemistry, Faculty of Pharmacy; M. S. Ramaiah University of Applied Sciences; Bengaluru Karnataka India

5. Department of Pharmacology; Father Muller Medical College; Mangalore Karnataka India

6. Department of Pharmacology; Karavali College of Pharmacy; Mangalore Karnataka India

7. Department of Pharmaceutical Chemistry; Sonia Education Trust's College of Pharmacy; Dharwad Karnataka India

8. Department of Pharmacy; Annamalai University; Chidambaram Tamil Nadu India

9. Department of Pharmacology, Faculty of Pharmacy; M. S. Ramaiah University of Applied Sciences; Bengaluru Karnataka India

Publisher

Wiley

Subject

Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3